Home News Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo

Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo

by AINI Secretariat

Multiple sclerosis involves an aberrant autoimmune response and progressive failure of remyelination in the central nervous system. Prevention of neural degeneration and subsequent disability requires remyelination through the generation of new oligodendrocytes, but current treatments exclusively target the immune system.